These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 28722500

  • 21. Efficacy and safety of multitarget therapy with cyclophosphamide and tacrolimus for lupus nephritis: a prospective, single-arm, single-centre, open label pilot study in Japan.
    Sakai R, Kurasawa T, Nishi E, Kondo T, Okada Y, Shibata A, Nishimura K, Chino K, Okuyama A, Takei H, Nagasawa H, Amano K.
    Lupus; 2018 Feb; 27(2):273-282. PubMed ID: 28683654
    [Abstract] [Full Text] [Related]

  • 22. Tacrolimus use in lupus nephritis: A systematic review and meta-analysis.
    Hannah J, Casian A, D'Cruz D.
    Autoimmun Rev; 2016 Jan; 15(1):93-101. PubMed ID: 26427983
    [Abstract] [Full Text] [Related]

  • 23. A Prospective Randomized, Comparative Trial of High-Dose Mizoribine Versus Mycophenolate Mofetil in Combination With Tacrolimus and Basiliximab for Living Donor Renal Transplant: A Multicenter Trial.
    Ishida H, Takahara S, Amada N, Tomikawa S, Chikaraishi T, Takahashi K, Uchida K, Akiyama T, Tanabe K, Toma H, Study Group for the Antimetabolite Comparison of Trial (AMCT).
    Exp Clin Transplant; 2016 Oct; 14(5):518-525. PubMed ID: 27733107
    [Abstract] [Full Text] [Related]

  • 24. Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis.
    Szeto CC, Kwan BC, Lai FM, Tam LS, Li EK, Chow KM, Gang W, Li PK.
    Rheumatology (Oxford); 2008 Nov; 47(11):1678-81. PubMed ID: 18753192
    [Abstract] [Full Text] [Related]

  • 25. Mizoribine: a new approach in the treatment of renal disease.
    Kawasaki Y.
    Clin Dev Immunol; 2009 Nov; 2009():681482. PubMed ID: 20052390
    [Abstract] [Full Text] [Related]

  • 26. Combined low-dose mycophenolate mofetil and tacrolimus for lupus nephritis with suboptimal response to standard therapy: a 12-month prospective study.
    Mok CC, To CH, Yu KL, Ho LY.
    Lupus; 2013 Oct; 22(11):1135-41. PubMed ID: 23995863
    [Abstract] [Full Text] [Related]

  • 27. Mizoribine oral pulse therapy for patients with disease flare of lupus nephritis.
    Tanaka H, Suzuki K, Nakahata T, Tsugawa K, Ito E, Waga S.
    Clin Nephrol; 2003 Dec; 60(6):390-4. PubMed ID: 14690255
    [Abstract] [Full Text] [Related]

  • 28. Effect of Tacrolimus vs Intravenous Cyclophosphamide on Complete or Partial Response in Patients With Lupus Nephritis: A Randomized Clinical Trial.
    Zheng Z, Zhang H, Peng X, Zhang C, Xing C, Xu G, Fu P, Ni Z, Chen J, Xu Z, Zhao MH, Li S, Huang X, Miao L, Chen X, Liu B, He Y, Li J, Liu L, Kadeerbai H, Liu Z, Liu Z.
    JAMA Netw Open; 2022 Mar 01; 5(3):e224492. PubMed ID: 35353167
    [Abstract] [Full Text] [Related]

  • 29. Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up.
    Mok CC, Ying KY, Yim CW, Siu YP, Tong KH, To CH, Ng WL.
    Ann Rheum Dis; 2016 Jan 01; 75(1):30-6. PubMed ID: 25550339
    [Abstract] [Full Text] [Related]

  • 30. Long-term Safety and Effectiveness of Tacrolimus in Patients With Lupus Nephritis: 5-year Interim Postmarketing Surveillance Study in Japan (TRUST).
    Takeuchi T, Wakasugi N, Uno S, Makino H.
    J Rheumatol; 2021 Jan 01; 48(1):74-81. PubMed ID: 32238515
    [Abstract] [Full Text] [Related]

  • 31. Long-term data on tacrolimus treatment in lupus nephritis.
    Yap DY, Ma MK, Mok MM, Kwan LP, Chan GC, Chan TM.
    Rheumatology (Oxford); 2014 Dec 01; 53(12):2232-7. PubMed ID: 24996908
    [Abstract] [Full Text] [Related]

  • 32. Comparison of tacrolimus and mizoribine in a randomized, double-blind controlled study in patients with rheumatoid arthritis.
    Kawai S, Hashimoto H, Kondo H, Murayama T, Kiuchi T, Abe T.
    J Rheumatol; 2006 Nov 01; 33(11):2153-61. PubMed ID: 16960930
    [Abstract] [Full Text] [Related]

  • 33. Tacrolimus versus cyclophosphamide as treatment for diffuse proliferative or membranous lupus nephritis: a non-randomized prospective cohort study.
    Wang S, Li X, Qu L, Wang R, Chen Y, Li Q, He X, Zhang X, Wang H, Wu J, Xu Y, Chen J.
    Lupus; 2012 Aug 01; 21(9):1025-35. PubMed ID: 22570338
    [Abstract] [Full Text] [Related]

  • 34. Efficacy and safety of tacrolimus for induction therapy in patients with active lupus nephritis.
    Takahashi S, Hiromura K, Sakurai N, Matsumoto T, Ikeuchi H, Maeshima A, Kaneko Y, Kuroiwa T, Nojima Y.
    Mod Rheumatol; 2011 Jun 01; 21(3):282-9. PubMed ID: 21188448
    [Abstract] [Full Text] [Related]

  • 35. Combination therapy of mycophenolate mofetil and tacrolimus in lupus nephritis.
    Lanata CM, Mahmood T, Fine DM, Petri M.
    Lupus; 2010 Jul 01; 19(8):935-40. PubMed ID: 20388722
    [Abstract] [Full Text] [Related]

  • 36. Low dose cyclosporine A in the treatment of resistant proliferative lupus nephritis.
    Sheikholeslami M, Hajialilo M, Rasi Hashemi SS, Malek Mahdavi A, Gojazadeh M, Khabbazi A.
    Mod Rheumatol; 2018 May 01; 28(3):523-529. PubMed ID: 28753077
    [Abstract] [Full Text] [Related]

  • 37. Induction therapy with low-dose intravenous cyclophosphamide, oral mizoribine, and steroids for severe lupus nephritis in children.
    Fujinaga S, Kaneko K, Ohtomo Y, Murakami H, Takada M, Akashi S, Hira M, Yamashiro Y.
    Pediatr Nephrol; 2005 Oct 01; 20(10):1500-3. PubMed ID: 16021476
    [Abstract] [Full Text] [Related]

  • 38. Combination therapy with steroids and mizoribine in juvenile SLE: a randomized controlled trial.
    Tanaka Y, Yoshikawa N, Hattori S, Sasaki S, Ando T, Ikeda M, Honda M, Japanese Study Group for Renal Disease in Children.
    Pediatr Nephrol; 2010 May 01; 25(5):877-82. PubMed ID: 19902267
    [Abstract] [Full Text] [Related]

  • 39. Mizoribine treatment of young patients with severe lupus nephritis: a clinicopathologic study by the tohoku pediatric study group.
    Tanaka H, Oki E, Tsuruga K, Sato N, Matsukura H, Matsunaga A, Kondo Y, Suzuki J.
    Nephron Clin Pract; 2008 May 01; 110(2):c73-9. PubMed ID: 18758186
    [Abstract] [Full Text] [Related]

  • 40. Effective treatment of young patients with pediatric-onset, long-standing lupus nephritis with tacrolimus given as a single daily dose: an open-label pilot study.
    Tanaka H, Oki E, Tsugawa K, Nonaka K, Suzuki K, Ito E.
    Lupus; 2007 May 01; 16(11):896-900. PubMed ID: 17971363
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.